Mediation of ocular tetrahydrocannabinol effects by adrenergic nervous system.
D000818:Animals; D001082:Aqueous Humor / Q000502:physiology; D003714:Denervation; D013759:Dronabinol / Q000494:pharmacology*; D005123:Eye / Q000294:innervation; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007429:Intraocular Pressure / Q000187:drug effects*; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D013564:Sympathetic Nervous System / Q000502:physiology*
D006584:Hexamethonium Compounds; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D013759:Dronabinol; D007213:Indomethacin